resveratrol has been researched along with pemetrexed in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Chen, HJ; Chen, RS; Chiu, HC; Huang, YC; Huang, YJ; Jian, YJ; Ko, JC; Lee, WT; Lin, YW; Tseng, SC; Wo, TY | 1 |
Abdelaziz, HM; Elzoghby, AO; Fang, JY; Freag, MS; Helmy, MW; Samaha, MW | 1 |
3 other study(ies) available for resveratrol and pemetrexed
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Endonucleases; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Lung Neoplasms; MAP Kinase Kinase 3; MAP Kinase Kinase 6; p38 Mitogen-Activated Protein Kinases; Pemetrexed; Protein Kinase Inhibitors; Resveratrol; RNA Interference; RNA, Messenger; Signal Transduction; Stilbenes; Time Factors; Transfection | 2013 |
Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Cell Proliferation; Drug Delivery Systems; Humans; Liquid Crystals; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Pemetrexed; Resveratrol; Tumor Cells, Cultured; Urethane | 2019 |